Portola Pharmaceuticals
| Use attributes for filter ! | |
| Stock price | PTLA |
|---|---|
| Disclaimer | |
| Revenue | 40,130 USD (2018) |
| Headquarters | South San Francisco |
| California | |
| United States | |
| CFO | Mardi C. Dier |
| Number of employees | 324 (2018) |
| Founded | 2003 |
| Founders | Charles J. Homcy |
| David R. Philips | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2438420 |
About Portola Pharmaceuticals
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies.
